Advertisement

Effects of constant rate infusions of dexmedetomidine, remifentanil and their combination on minimum alveolar concentration of sevoflurane in dogs

Published:April 17, 2020DOI:https://doi.org/10.1016/j.vaa.2020.04.002

      Abstract

      Objective

      To evaluate the effects of constant rate infusions (CRIs) of dexmedetomidine and remifentanil alone and their combination on minimum alveolar concentration (MAC) of sevoflurane in dogs.

      Study design

      Randomized crossover experimental study.

      Animals

      A total of six (three males, three females) healthy, adult neutered Beagle dogs weighing 12.6 ± 1.4 kg.

      Methods

      Anesthesia was induced with sevoflurane in oxygen until endotracheal intubation was possible and anesthesia maintained with sevoflurane using positive-pressure ventilation. Each dog was anesthetized five times and was administered each of the following treatments: saline (1 mL kg–1 hour–1) or dexmedetomidine at 0.1, 0.5, 1.0 or 5.0 μg kg–1 loading dose intravenously over 10 minutes followed by CRI at 0.1, 0.5, 1.0 or 5.0 μg kg–1 hour–1, respectively. Following 60 minutes of CRI, sevoflurane MAC was determined in duplicate using an electrical stimulus (50 V, 50 Hz, 10 ms). Then, CRI of successively increasing doses of remifentanil (0.15, 0.60 and 2.40 μg kg–1 minute–1) was added to each treatment. MAC was also determined after 30 minutes equilibration at each remifentanil dose. Isobolographic analysis determined interaction from the predicted doses required for a 50% MAC reduction (ED50) with remifentanil, dexmedetomidine and remifentanil combined with dexmedetomidine, with the exception of dexmedetomidine 5.0 μg kg–1 hour–1, obtained using log-linear regression analysis.

      Results

      The sevoflurane MAC decreased dose-dependently with increasing infusion rates of dexmedetomidine and remifentanil. Remifentanil ED50 values were lower when combined with dexmedetomidine than those obtained during saline–remifentanil. Synergistic interactions between dexmedetomidine and remifentanil for MAC reduction occurred with dexmedetomidine at 0.5 and 1.0 μg kg–1 hour–1.

      Conclusions and clinical relevance

      Combined CRIs of dexmedetomidine and remifentanil synergistically resulted in sevoflurane MAC reduction. The combination of dexmedetomidine and remifentanil effectively reduced the requirement of sevoflurane during anesthesia in dogs.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Veterinary Anaesthesia and Analgesia
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Allweiler S.
        • Brodbelt D.C.
        • Borer K.
        • et al.
        The isoflurane-sparing and clinical effects of a constant rate infusion of remifentanil in dogs.
        Vet Anaesth Analg. 2007; 34: 388-393
        • Antognini J.F.
        • Schwartz K.
        Exaggerated anesthetic requirements in the preferentially anesthetized brain.
        Anesthesiology. 1993; 79: 1244-1249
        • Bloor B.C.
        • Frankland M.
        • Alper G.
        • et al.
        Hemodynamic and sedative effects of dexmedetomidine in dog.
        J Pharmacol Exp Ther. 1992; 263: 690-697
        • Burkle H.
        • Dunbar S.
        • Van Aken H.
        Remifentanil: a novel, short-acting, mu-opioid.
        Anesth Analg. 1996; 83: 646-651
        • Chabot-Doré A.J.
        • Schuster D.J.
        • Stone L.S.
        • Wilcox G.L.
        Analgesic synergy between opioid and α2-adrenoceptors.
        Br J Pharmacol. 2015; 172: 388-402
        • Chism J.P.
        • Rickert D.E.
        The pharmacokinetics and extra-hepatic clearance of remifentanil, a short acting opioid agonist, in male beagle dogs during constant rate infusions.
        Drug Metab Dispos. 1996; 24: 34-40
        • Ebner L.S.
        • Lerche P.
        • Bednarski R.M.
        • Hubbell J.A.
        Effect of dexmedetomidine, morphine-lidocaine-ketamine, and dexmedetomidine-morphine-lidocaine-ketamine constant rate infusions on the minimum alveolar concentration of isoflurane and bispectral index in dogs.
        Am J Vet Res. 2013; 74: 963-970
        • Eger II, E.I.
        • Saidman L.J.
        • Brandstater B.
        Minimum alveolar anesthetic concentration: a standard of anesthetic potency.
        Anesthesiology. 1965; 26: 756-763
        • Gessner P.K.
        Isobolographic analysis of interactions: an update on applications and utility.
        Toxicology. 1995; 105: 161-179
        • Hector R.C.
        • Rezende M.L.
        • Mama K.R.
        • et al.
        Effects of constant rate infusions of dexmedetomidine or MK-467 on the minimum alveolar concentration of sevoflurane in dogs.
        Vet Anaesth Analg. 2017; 44: 755-765
        • Hoke J.F.
        • Cunningham F.
        • James M.K.
        • et al.
        Comparative pharmacokinetics and pharmacodynamics of remifentanil, its principle metabolite (GR90291) and alfentanil in dogs.
        J Pharmacol Exp Ther. 1997; 281: 226-232
        • Kuusela E.
        • Raekallio M.
        • Anttila M.
        • et al.
        Clinical effects and pharmacokinetics of medetomidine and its enantiomers in dogs.
        J Vet Pharmacol Ther. 2000; 23: 15-20
        • Lin G.Y.
        • Robben J.H.
        • Murrell J.C.
        • et al.
        Dexmedetomidine constant rate infusion for 24 hours during and after propofol or isoflurane anaesthesia in dogs.
        Vet Anaesth Analg. 2008; 35: 141-153
        • Matute E.
        • Rivera-Arconada I.
        • López-Garcia J.A.
        Effects of propofol and sevoflurane on the excitability of rat spinal motoneurones and nociceptive reflexes in vitro.
        Br J Anaesth. 2004; 93: 422-427
        • Michelsen L.G.
        • Salmenperä M.
        • Hug C.C.
        • et al.
        Anesthetic potency of remifentanil in dogs.
        Anesthesiology. 1996; 84: 865-872
        • Monteiro E.R.
        • Teixeira-Neto F.J.
        • Campagnol D.
        • et al.
        Effects of remifentanil on the minimum alveolar concentration of isoflurane in dogs.
        Am J Vet Res. 2010; 71: 150-156
        • Monteiro E.R.
        • Neto F.J.
        • Campagnol D.
        • et al.
        Hemodynamic effects in dogs anesthetized with isoflurane and remifentanil-isoflurane.
        Am J Vet Res. 2010; 71: 1133-1141
        • Moran-Muñoz R.
        • Ibancovichi J.A.
        • Gutierrez-Blanco E.
        • et al.
        Effects of lidocaine, dexmedetomidine or their combination on the minimum alveolar concentration of sevoflurane in dogs.
        J Vet Med Sci. 2014; 76: 847-853
        • Muir III, W.W.
        • Wiese A.J.
        • March P.A.
        Effects of morphine, lidocaine, ketamine and morphine-lidocaine-ketamine drug combination on minimum alveolar concentration in dogs anesthetized with isoflurane.
        Am J Vet Res. 2003; 64: 1155-1160
        • Murahata Y.
        • Hikasa Y.
        • Hayashi S.
        • et al.
        The effect of remifentanil on the minimum alveolar concentration (MAC) and MAC derivatives of sevoflurane in dogs.
        J Vet Med Sci. 2018; 80: 1086-1093
        • Murrell J.C.
        • Hellebrekers L.J.
        Medetomidine and dexmedetomidine: a review of cardiovascular effects and antinociceptive properties in the dog.
        Vet Anaesth Analg. 2005; 32: 117-127
        • Murrell J.C.
        • van Notten R.W.
        • Hellebrekers L.J.
        Clinical investigation of remifentanil and propofol for the total intravenous anaesthesia of dogs.
        Vet Rec. 2005; 156: 804-808
        • Mutoh T.
        • Nishimura R.
        • Kim H.Y.
        • et al.
        Cardiopulmonary effects of sevoflurane, compared with halothane, enflurane, and isoflurane, in dogs.
        Am J Vet Res. 1997; 58: 885-890
        • Ossipov M.H.
        • Harris S.
        • Lloyd P.
        • et al.
        Antinociceptive interaction between opioids and medetomidine: systemic additivity and spinal synergy.
        Anesthesiology. 1990; 73: 1227-1235
        • Pascoe P.J.
        The cardiopulmonary effects of dexmedetomidine infusions in dogs during isoflurane anesthesia.
        Vet Anaesth Analg. 2015; 42: 360-368
        • Pascoe P.J.
        • Raekallio M.
        • Kuusela E.
        • et al.
        Changes in the minimum alveolar concentration of isoflurane and some cardiopulmonary measurements during three continuous infusion rates of dexmedetomidine in dogs.
        Vet Anaesth Analg. 2006; 33: 97-103
        • Quasha A.L.
        • Eger II, El
        • Tinker J.H.
        Determination and application of MAC.
        Anesthesiology. 1980; 53: 315-334
        • Salmenperä M.T.
        • Szlam F.
        • Hug Jr, C.C.
        Anesthetic and hemodynamic interactions of dexmedetomidine and fentanyl in dogs.
        Anesthesiology. 1994; 80: 837-846
        • Shinohara K.
        • Aono H.
        • Unruh G.K.
        • et al.
        Suppressive effects of remifentanil on hemodynamics in baro-denervated rabbits.
        Can J Anaesth. 2000; 47: 361-366
        • Tallarida R.J.
        Revisiting the isobole and related quantitative methods for assessing drug synergism.
        J Pharmacol Exp Ther. 2012; 342: 2-8
        • Uilenreef J.J.
        • Murrell J.C.
        • McKusick B.C.
        • Hellebrekers L.J.
        Dexmedetomidine continuous rate infusion during isoflurane anaesthesia in canine surgical patients.
        Vet Anaesth Analg. 2008; 35: 1-12
        • Valtolina C.
        • Robben J.H.
        • Uilenreef J.
        • et al.
        Clinical evaluation of the efficacy and safety of a constant rate infusion of dexmedetomidine for postoperative pain management in dogs.
        Vet Anaesth Analg. 2009; 36: 369-383
        • Valverde A.
        • Morey T.E.
        • Hernández J.
        • Davies W.
        Validation of several types of noxious stimuli for use in determining the minimum alveolar concentration for inhalation anesthetics in dogs and rabbits.
        Am J Vet Res. 2003; 64: 957-962
        • Voigt A.M.
        • Bergfeld C.
        • Beyerbach M.
        • Kästner S.B.
        Effects of isoflurane with and without dexmedetomidine or remifentanil on heart rate variability before and after nociceptive stimulation at different multiples of minimum alveolar concentration in dogs.
        Am J Vet Res. 2013; 74: 665-671